SOLICITATION NOTICE
66 -- Three-Dimensional Printer (3DP) - RFQ-FDA-1160592
- Notice Date
- 1/8/2016
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 334118
— Computer Terminal and Other Computer Peripheral Equipment Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services - Rockville, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001, United States
- ZIP Code
- 20857-0001
- Solicitation Number
- RFQ-FDA-1160592
- Archive Date
- 1/29/2016
- Point of Contact
- Sean Wybenga, Phone: 240-402-7629
- E-Mail Address
-
sean.wybenga@fda.hhs.gov
(sean.wybenga@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- RFQ-FDA-1160592 (3DP) DESCRIPTION THIS IS A COMBINED SYNOPSIS/SOLICITATION FOR COMMERCIAL ITEMS PREPARED IN ACCORDANCE WITH FAR SUBPART 13.5-SIMPLIFIED PROCEDURES FOR CERTAIN COMMERCIAL ITEMS AND 12.6-STREAMLINED PROCEDURES FOR EVALUATION AND SOLICITATION FOR COMMERCIAL ITEMS-AS SUPPLEMENTED WITH ADDITIONAL INFORMATION INCLUDED IN THIS NOTICE. THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION; PROPOSALS ARE BEING REQUESTED, AND A WRITTEN SOLICITATION DOCUMENT WILL NOT BE ISSUED. This solicitation is being issued as a Request for Quote (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-84. This requirement is a small business set-aside. The associated North American Industrial Classification System (NAICS) code for this procurement is 334118 with a size standard of 1,000 employees. The Government intends to award a firm fixed price order. This is a brand name or equal requirement for a ProJet 460Plus 3D Printer. BACKGROUND: DPQR requires one (1) 3DP to fulfill its regulatory research role and perform layered manufacturing product development. 3D printing is an emerging manufacturing technology and is used by various industries to manufacture prototype objects. It also finds application in biomedical engineering and pharmaceutical manufacturing. Currently, there is a NDA submission based on this technique. DPQR will use the 3DP to understand the manufacturing science of 3D layered manufacturing technology to be used in the pharmaceutical industry and to understand the impact on the product quality of drug products. Therefore, DPQR requires one (1) 3DP with specifications outline in the ‘Technical Evaluation Criteria' (see attachment). ITEM 0001: 3D Printer Apparatus Salient Characteristics FDA requires a newly manufactured and not refurbished 3D printer with the following characteristics and components: • 3D Pinter technologies based on powder bed printing (binder jetting or layered manufacturing) • Approximate dimensions 48 X 31 X 55 inches • Two printing heads capable of working simultaneously • Capable of handling both binder solution and core solid material for pharmaceutical applications • Minimum feature size - 0.006 inches (0.15 mm) • Layer thickness - 0.004 inches (0.1 mm) • Vertical Build Speed - 0.9 inch/hour (23 mm/hour) • Prototypes per Build - 18 • Net Build Volume (xyz) - 8 x 10 x 8 inches (203 x 254 x 203 mm) • Number of Jets - 2 • Fine Core Removal shall be integrated • Software shall be included • Operating Temperature Range - 55-75°F (13 - 24 °C) • Operating Humidity Range - 20-55% - non-condition • PC workstation and 17'' LCD monitor • Tools kits and reference samples ITEM 0002: Training One day training and follow up training if needed, on how to use the hardware and software of the 3D printer system for at least ten individuals. ITEM 0003: Option 1: Extended warranty/preventative maintenance 3DP One (1) year extended warranty/preventative maintenance and shall include repair of the machine and coverage of all parts. MAINTENANCE REQUIREMENTS: The vendor shall, commensurate with the completion of each service call, provide the end user of the equipment with a copy of the field service report/ticket identifying the equipment name, manufacturer, model number, and serial number of the equipment being serviced/repaired and detailing the reason for the service call, a detailed description of the work performed, the test instruments or other equipment used to affect the repair or otherwise perform the service, the name(s) and contact information of the technician who performed the repair/service, and for information purposes, on-site hours expended and parts/components replaced. In addition, the vendor shall provide monthly reports to the FDA COR and Contract Specialist, not later than the 5th workday following the end of each month, summarizing all maintenance and repair activities (including warranty work) for the previous month; negative reports are required. PERIOD OF PERFORMANCE: • The 3D printer shall be installed within 90 days from the effective date of the order. • The warranty on maintenance and parts shall be one (1) year from installation. • The optional extended warranty shall be one (1) year from the expiration of the warranty. • The total period of performance inclusive of the option shall be no longer than two (2) years and 90 days.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/RFQ-FDA-1160592/listing.html)
- Place of Performance
- Address: Food and Drug Administration, 10903 New Hampshire Avenue, Building 62, Silver Spring, Maryland, 20993, United States
- Zip Code: 20993
- Zip Code: 20993
- Record
- SN03986486-W 20160110/160109132518-77a00d93c1baad8c3db870ebbdee6b52 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |